ASMB
Income statement / Annual
Last year (2024), Assembly Biosciences, Inc.'s total revenue was $28.52 M,
an increase of 298.16% from the previous year.
In 2024, Assembly Biosciences, Inc.'s net income was -$40.18 M.
See Assembly Biosciences, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$28.52 M |
$7.16 M |
$0.00 |
$6.25 M |
$79.11 M |
$15.96 M |
$14.80 M |
$9.02 M |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$48.90 M
|
$69.08 M
|
$0.00
|
$101.34 M
|
$85.32 M
|
$72.74 M
|
$44.23 M
|
$80.25 K
|
$64.99 K
|
| Gross Profit |
$28.52 M
|
-$41.74 M
|
-$69.08 M
|
$6.25 M
|
-$22.23 M
|
-$69.36 M
|
-$57.94 M
|
-$35.21 M
|
-$80.25 K
|
-$64.99 K
|
| Gross Profit Ratio |
1
|
-5.83
|
0
|
1
|
-0.28
|
-4.35
|
-3.91
|
-3.9
|
0
|
0
|
| Research and Development Expenses |
$55.93 M
|
$48.90 M
|
$69.98 M
|
$68.52 M
|
$106.82 M
|
$85.76 M
|
$72.74 M
|
$44.23 M
|
$33.09 M
|
$18.36 M
|
| General & Administrative Expenses |
$18.01 M
|
$22.91 M
|
$23.93 M
|
$28.78 M
|
$36.86 M
|
$34.86 M
|
$34.80 M
|
$17.02 M
|
$12.19 M
|
$11.30 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$18.01 M
|
$22.91 M
|
$23.93 M
|
$28.78 M
|
$36.86 M
|
$34.86 M
|
$34.80 M
|
$17.02 M
|
$12.19 M
|
$11.30 M
|
| Other Expenses |
$0.00
|
-$48.90 M
|
-$68.88 M
|
$41.64 M
|
-$101.14 M
|
-$87.26 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$73.94 M
|
$22.91 M
|
$25.03 M
|
$138.94 M
|
$42.54 M
|
$33.35 M
|
$107.54 M
|
$61.25 M
|
$45.28 M
|
$29.66 M
|
| Cost And Expenses |
$73.94 M
|
$71.81 M
|
$94.11 M
|
$138.94 M
|
$143.88 M
|
$118.68 M
|
$107.54 M
|
$61.25 M
|
$45.28 M
|
$29.66 M
|
| Interest Income |
$5.57 M
|
$3.45 M
|
$1.02 M
|
$302.00 K
|
$2.62 M
|
$4.31 M
|
$3.08 M
|
$983.21 K
|
$1.54 M
|
$1.23 M
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$129.00 K
|
$450.00 K
|
$498.00 K
|
$466.00 K
|
$691.00 K
|
$494.00 K
|
$643.00 K
|
$219.23 K
|
$80.25 K
|
$64.99 K
|
| EBITDA |
-$45.29 M |
-$64.20 M |
-$92.52 M |
-$90.58 M |
-$58.40 M |
-$103.73 M |
-$92.74 M |
-$52.01 M |
-$44.80 M |
-$29.59 M |
| EBITDA Ratio |
-1.59
|
-8.96
|
0
|
-14.48
|
-0.74
|
-6.5
|
-6.26
|
-5.77
|
0
|
0
|
| Operating Income Ratio |
-1.59
|
-9.02
|
0
|
-21.22
|
-0.82
|
-6.43
|
-6.26
|
-5.79
|
0
|
0
|
| Total Other Income/Expenses Net |
$5.57 M
|
$3.45 M
|
$1.02 M
|
$302.00 K
|
$2.62 M
|
$5.85 M
|
$3.08 M
|
$368.20 K
|
$398.77 K
|
$1.20 M
|
| Income Before Tax |
-$39.85 M
|
-$61.20 M
|
-$93.09 M
|
-$132.39 M
|
-$62.15 M
|
-$96.86 M
|
-$89.65 M
|
-$51.86 M
|
-$44.88 M
|
-$28.45 M
|
| Income Before Tax Ratio |
-1.4
|
-8.54
|
0
|
-21.17
|
-0.79
|
-6.07
|
-6.06
|
-5.75
|
0
|
0
|
| Income Tax Expense |
$330.00 K
|
$33.00 K
|
$0.00
|
-$2.53 M
|
$0.00
|
$774.00 K
|
$1.10 M
|
-$9.05 M
|
-$617.67 K
|
$0.00
|
| Net Income |
-$40.18 M
|
-$61.23 M
|
-$93.09 M
|
-$129.86 M
|
-$62.15 M
|
-$97.63 M
|
-$90.75 M
|
-$42.81 M
|
-$44.26 M
|
-$28.45 M
|
| Net Income Ratio |
-1.41
|
-8.55
|
0
|
-20.76
|
-0.79
|
-6.12
|
-6.13
|
-4.75
|
0
|
0
|
| EPS |
-6.69 |
-13.38 |
-22.82 |
-36 |
-15 |
-27.8 |
-39.8 |
-24.1 |
-25.7 |
-18.1 |
| EPS Diluted |
-6.69 |
-13.38 |
-22.82 |
-36 |
-15 |
-27.8 |
-39.8 |
-24.1 |
-25.7 |
-18.1 |
| Weighted Average Shares Out |
$6.00 M
|
$4.58 M
|
$4.03 M
|
$3.61 M
|
$3.97 M
|
$3.51 M
|
$2.28 M
|
$1.78 M
|
$1.72 M
|
$1.57 M
|
| Weighted Average Shares Out Diluted |
$6.00 M
|
$4.58 M
|
$4.03 M
|
$3.61 M
|
$3.97 M
|
$3.51 M
|
$2.28 M
|
$1.78 M
|
$1.72 M
|
$1.57 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
